Supreme Court’s Subjective Intent Requirement In Prescription Drug Cases Could Have Far-Reaching Implications In White-Collar Prosecutions – Trials & Appeals & Compensation
To print this article, all you need is to be registered or login on Mondaq.com. Hidden among its flurry of end-of-term blockbusters, on June 27, 2022, the US Supreme Court issued a long-awaited opinion in Ruan v. United States. In Ruan, the Supreme Court addressed the issue of what mens rea A physician…